← Back to Clinical Trials
Recruiting Phase 3 NCT06575192

Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult Participants

Trial Parameters

Condition Breast Reconstruction
Sponsor AbbVie
Study Type INTERVENTIONAL
Phase Phase 3
Enrollment 783
Sex FEMALE
Min Age 18 Years
Max Age N/A
Start Date 2024-11-05
Completion 2029-12
Interventions
ARTIA Reconstructive Tissue MatrixNo Intervention

Brief Summary

The purpose of this study is to evaluate the safety and effectiveness of ARTIA in adult participants undergoing immediate, two-stage, implant-based breast reconstruction post-mastectomy.

Eligibility Criteria

Inclusion Criteria: * Participants who will undergo unilateral or bilateral mastectomy upon enrollment. * Participants who are willing and able to undergo immediate pre-pectoral two-stage breast reconstruction with ARTIA or without ADM. Exclusion Criteria: * Has an existing carcinoma of the breast without planned mastectomy or residual gross local tumor of the breast after mastectomy. * Has any disease which is clinically known to impact wound healing ability, such as uncontrolled diabetes or history of compromised wound healing.

Related Trials